Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The Cleveland Clinic
With
National Institute on Aging (NIA)
This 24-week study will examine the sensitivity of functional MRI to detect brain changes caused by donepezil HCL (a cholinesterase inhibitor) in healthy older adults at genetic risk for Alzheimer's Disease. Participants with a family history of Alzheimer's Disease will be eligible for this study. Participants without a family history of AD will also be enrolled to serve as a control group.
Age
60–75
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Normal general cognitive function
High Risk Group Only: Family history (1st degree relative) of AD
Low Risk Group Only: No family history (1st or 2nd degree relative) of AD
Visual and auditory acuity adequate for neuropsychological testing
You may not be if
Current or past history of
neurological illnesses/conditions
head trauma with significant loss of consciousness
medical illnesses/conditions that may affect brain function
severe psychiatric disorder
substance abuse
unstable or severe cardiovascular disease or asthmatic condition